|
US6306434B1
|
|
Pharmaceutical composition comprising cyclosporin solid-state microemulsion
|
|
ZA9810885B
|
|
Cyclosporin-containing microemulsion preconcentrate composition
|
|
US6063762A
|
|
Cyclosporin-containing microemulsion preconcentrate composition
|
|
ZA9804796B
|
|
Novel optically active nucleoside derivative its manufacturing method and anti-HBV composition containing the derivative thereof
|
|
US6028067A
|
|
Cyclosporin-containing microemulsion preconcentrate composition
|
|
US6048540A
|
|
Acetamenophen composition with reduced liver toxicity
|
|
US5980939A
|
|
Cyclosporin-containing pharmaceutical composition
|
|
AU1559597A
|
|
Compounds having dopamine beta-hydroxylase inhibitory activity
|
|
CA2235598A1
|
|
Novel nucleoside derivatives and process for preparing the same
|
|
AU7340696A
|
|
Sulfoxide derivatives of nitrogen-mustard and anticancer agent containing the same
|
|
AU4400696A
|
|
Camptothecin derivatives and its manufacturing method
|
|
CA2208707A1
|
|
Novel aminooligosaccharide derivative and process for preparing the same
|
|
EP0869953A1
|
|
Nucleoside derivatives and process for preparing thereof
|
|
CN1161694A
|
|
Nucleoside derivatives and process for preparing same
|
|
AU3674395A
|
|
Process for manufacturing cyclosporin a by highly productive fusant strain
|
|
EP0702562A1
|
|
Cyclosporin-containing powder composition
|
|
AU5717894A
|
|
2-(2-substituted pyrrolidin-4-yl)thio-carbapenem derivatives
|
|
KR950000031B1
|
|
Process for preparing bezoar solution
|
|
KR890001281B1
|
|
Process of preparing 3-hydroxy-3-cephem compounds
|
|
KR890001405B1
|
|
Process for preparing benzimidazole derivatives
|
